Phase 3 Study of Ibrutinib in Combination with Venetoclax in Subjects with Mantle Cell Lymphoma

Clinical Trial Grant

Duke Scholars

Principal Investigator Matthew Stuart McKinney Medicine, Hematologic Malignancies and Cellular Therapy

Administered By

Duke Cancer Institute

Awarded By

Pharmacyclics, Inc.

Start Date

September 18, 2018

End Date

July 8, 2020

Administered By

Duke Cancer Institute

Awarded By

Pharmacyclics, Inc.

Start Date

September 18, 2018

End Date

July 8, 2020